Neurocrine Biosciences Reports First-Quarter 2026 Financial Results
Go back to Neurocrine Biosciences Reports First-Quarter 2026 Financial Results| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 155.01 +2.08 (1.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $152.93 | 52 Week High | $58.46 | |||
| Open | $153.13 | 52 Week Low | $31.25 | |||
| Day High | $155.27 | P/E | N/A | |||
| Day Low | $152.65 | EPS | $-0.69 | |||
| Volume | 515,969 | |||||

